Publications

genyo-centro-pzifer-universidad-granada-07

Home - Research - Publications

2024
2023
2022
Previous publications

From Bench to Bedside: Ethical and Clinical Best Practices for Genome Editing Applications.

Authors: Ortiz-Bueno M, Zinghirino F, Serra PP, Paschoudi K, Montoliu L, Atilla E, Luo Y, Cavazza A, Lederer CW, Benabdellah K

02/2026 - International journal of molecular sciences

RBM10 modulation of circRNA biogenesis contributes to its tumor suppressor role in lung adenocarcinoma.

Authors: Utrilla-Maestre A, Matia-González AM, Peinado P, Becerra-Rodriguez MA, Benitez-Cantos MS, Cuadros M, Medina PP

02/2026 - Biomarker research

Old and new autoantibodies in systemic lupus erythematosus.

Authors: Parodis I, Nikolopoulos D, Brylid A, Hultgren O, Alarcón-Riquelme ME, Sjöwall C

02/2026 - Expert review of clinical immunology

Network analysis of longitudinal electronic health records using linear mixed models.

Authors: Vargas-Fernández M, Luna JD, Martorell-Marugán J, Carmona-Sáez P

02/2026 - BioData mining

ADAMTS proteases in extracellular vesicles: emerging mediators of extracellular matrix dynamics and disease progression.

Authors: Peris-Torres C, Rodríguez-Manzaneque JC

02/2026 - The FEBS journal

Liquid biopsy biomarkers for accurate detection of malignant pulmonary nodules: a meta-analytic approach.

Authors: Caballero-Vazquez A, Garcia-Cerezo M, Fernandez-Castro LR, Morales-Garcia C, Lainez Ramos-Bossini AJ, Vergara-Rubio F, Ortega-Sanchez FG, Sanchez-Maldonado JM

01/2026 - Discover oncology

Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosus.

Authors: Parodis I, Iacubino M, Rocco L, Nikolopoulos D, Palazzo L, Grimmett L, Kerr M, Bellocchi C, Vigone B, Santaniello A, Barturen G, Voskuyl AE, Alarcón-Riquelme ME, Beretta L

01/2026 - Annals of the rheumatic diseases

Functional in vitro assessment of the HER2 Ile655Val variant on trastuzumab-induced cardiotoxicity in human cardiomyocytes.

Authors: Pozo-Agundo A, García-Rodríguez S, Antúnez-Rodríguez A, Chica-Redecillas L, Cejas RB, Lyra-Leite D, Porras-Quesada P, Gómez-Sánchez J, Mirón-Pozo B, Álvarez-Cubero MJ, Burridge PW, Martin F, Martínez-González LJ, Dávila-Fajardo CL

01/2026 - European journal of pharmacology

Corrigendum to "International expert consensus on the clinical integration of circulating tumor cells in solid tumors" [Eur. J. Cancer 231 (2025) 116050].

Authors: Nicolò E, Reduzzi C, Pierga JY, Gazzaniga P, Stoecklein NH, Denninghoff V, Rothwell DG, De Bono JS, Marchetti D, Lianidou E, Riethdorf S, Generali D, Hofman P, Gerratana L, Kuhn P, Thiery JP, Ignatiadis M, Bidard FC, Lucci A, Kasimir-Bauer S, Serrano MJ, Cristofanilli M

01/2026 - European journal of cancer (Oxford, England : 1990)

Short communication: Dynamic chemical labelling allows the measurement of the paracetamol toxicity biomarker microRNA-122 in hospital clinical laboratories.

Authors: Alzeer S, Marin-Romero A, López-Longarela B, Guardia-Monteagudo JJ, Lopez-Delgado FJ, Pernagallo S, Diaz-Mochon JJ, Tabraue-Chavez M, Scullion K, Dear JW

02/2026 - British journal of clinical pharmacology

Tigecycline suppresses colon cancer stem cells and impairs tumor engraftment by targeting SNAI1-regulated epithelial-mesenchymal transition.

Authors: Ruiz-Malagón AJ, Rodríguez-Sojo MJ, García-García J, Ho-Plagaro A, García F, Vezza T, Redondo-Cerezo E, Griñán-Lisón C, Marchal JA, Rodríguez-Cabezas ME, Rodríguez-Nogales A, Gálvez J

01/2026 - Acta pharmacologica Sinica

Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus.

Authors: Garantziotis P, Beretta L, Lindblom J, Moysidou GS, Nikolopoulos D, Grieshaber-Bouyer R, Hagen M, Bergmann C, Wirsching A, Bozec A, PRECISESADS Clinical Consortium, Schneider M, Barturen G, Bertsias G, Boumpas DT, Alarcón-Riquelme ME, Mackensen A, Schett G, Parodis I

01/2026 - Annals of the rheumatic diseases